News
FDA issued an Early Alert for Abiomed's Automated Impella Controllers due to potential safety concerns following reports of 3 ...
Zacks Investment Research on MSN5h
Will J&J's Q2 Results Reflect End of MedTech Issues & Higher Sales?Johnson & Johnson's JNJ medical devices segment, known as MedTech, offers products in the orthopedics, surgery, ...
Zacks Investment Research on MSN5d
Does J&J's Innovative Medicine Unit Hold the Key to Q2 Sales Growth?Johnson & Johnson JNJ, under its Innovative Medicine segment, markets several multi-million-dollar drugs that cover a broad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback